Exane Derivatives’s Kimberly-Clark KMB Stock Holding History

Exane Derivatives’s Portfolio KMB Stock Details KMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,671	Closed	-$822K	–	868
2022 Q1	$822K	Buy	6,671 +1,347	+25%	+$178K	0.23%	116
2021 Q4	$761K	Buy	5,324 +150	+3%	+$20.2K	0.18%	122
2021 Q3	$685K	Buy	5,174 +5,171	+172,367%	+$703K	0.16%	135
2021 Q2	$403	Hold	3	–	–	﹤0.01%	966
2021 Q1	$417	Hold	3	–	–	﹤0.01%	811
2020 Q4	$405	Sell	3 -42	-93%	-$5.88K	﹤0.01%	756
2020 Q3	$6.64K	Sell	45 -3,129	-99%	-$470K	﹤0.01%	488
2020 Q2	$449K	Buy	3,174 +3,166	+39,575%	+$437K	0.12%	150
2020 Q1	$1.02K	Hold	8	–	–	﹤0.01%	546
2019 Q4	$1.14K	Sell	8 -818	-99%	-$111K	﹤0.01%	536
2019 Q3	$117K	Sell	826 -885	-52%	-$122K	0.02%	305
2019 Q2	$228K	Sell	1,711 -1,489	-47%	-$192K	0.04%	249
2019 Q1	$396K	Sell	3,200 -602	-16%	-$70K	0.08%	171
2018 Q4	$433K	Hold	3,802	–	–	0.08%	188
2018 Q3	$431K	Sell	3,802 -3,348	-47%	-$375K	0.08%	170
2018 Q2	$757K	Sell	7,150 -19,007	-73%	-$1.97M	0.13%	145
2018 Q1	$2.86M	Buy	26,157 +22,045	+536%	+$2.51M	0.57%	34
2017 Q4	$496K	Sell	4,112 -163	-4%	-$19K	0.09%	164
2017 Q3	$503K	Buy	4,275 +841	+24%	+$103K	0.09%	135
2017 Q2	$443K	Buy	3,434 +791	+30%	+$103K	0.1%	144
2017 Q1	$348K	Buy	2,643 +1,721	+187%	+$217K	0.08%	156
2016 Q4	$105K	Buy	922 +879	+2,044%	+$102K	0.02%	244
2016 Q3	$5.42K	Buy	+43	New	+$5.56K	﹤0.01%	440
2015 Q3	–	Sell	-213,892	Closed	-$22.7M	–	558
2015 Q2	$22.7M	Buy	+213,892	New	+$23.3M	2.44%	16

Other funds holding KMB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Exane Derivatives's KMB Position: Q2 2022 in Review

Exane Derivatives sold out of Kimberly-Clark (KMB) in Q2 2022, closing a stake of 6,671 shares — an estimated $822K sold.

Exane Derivatives first reported a position in KMB in Q2 2015 and held it in 24 quarters. The position peaked at $22.7M in Q2 2015. 1,634 funds tracked by Wall St. Rank hold KMB as of Q2 2022.

Exane Derivatives reported no remaining Kimberly-Clark position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 6,671 Kimberly-Clark shares in Q2 2022, an estimated $822K.
Exane Derivatives first reported a position in Kimberly-Clark in Q2 2015 and held it in 24 quarters.
Exane Derivatives's Kimberly-Clark position peaked at $22.7M in Q2 2015.
1,634 funds tracked by Wall St. Rank held Kimberly-Clark as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.